PMID: 9431957Feb 12, 1998Paper

First report of a human isolate of Erwinia persicinus

Journal of Clinical Microbiology
C M O'HaraD J Brenner

Abstract

Erwinia persicinus was first described in 1990 after being isolated from a variety of fruits and vegetables, including bananas, cucumbers, and tomatoes. In 1994, it was shown to be the causative agent of necrosis of bean pods. We now report the first human isolate of E. persicinus. The strain was isolated from the urine of an 88-year-old woman who presented with a urinary tract infection. By the hydroxyapatite method, DNA from this strain was shown to be 94.5% related at 60 degrees C and 86% related at 75 degrees C to the type strain of E. persicinus. The biochemical profile of E. persicinus is most similar to those of Erwinia rhapontici, Pantoea agglomerans, and Enterobacter species. It is negative in tests for lysine, arginine, ornithine, dulcitol, and urea. It is motile and positive in tests for D-sorbitol and sucrose. It is susceptible to the expanded-spectrum cephalosporins, aminoglycosides, and fluoroquinolones, but it is resistant to ampicillin, ticarcillin, and cefazolin.

References

Oct 1, 1990·International Journal of Systematic Bacteriology·M V HaoK Komagata
Jun 1, 1982·Journal of Clinical Microbiology·D J BrennerA G Steigerwalt
Apr 1, 1994·International Journal of Systematic Bacteriology·D J BrennerC F Robbs

❮ Previous
Next ❯

Citations

Oct 18, 2002·Antimicrobial Agents and Chemotherapy·Sophie VimontPatrice Nordmann
Oct 9, 2004·The Journal of Antimicrobial Chemotherapy·Thierry NaasPatrice Nordmann
Dec 8, 2015·Frontiers in Microbiology·Bukola R Aremu, Olubukola O Babalola
Apr 21, 2020·Environmental Microbiology·Jun-Seob KimChoong-Min Ryu
Mar 1, 2007·FEMS Microbiology Reviews·Peter van BaarlenBart P H J Thomma
Apr 28, 2018·International Journal of Environmental Research and Public Health·Beata GutarowskaKatarzyna Majchrzycka
Jul 11, 2008·Journal of Clinical Microbiology·Sang Yop ShinKwan Soo Ko
Aug 8, 2021·International Journal of Molecular Sciences·Fernando Sanz-GarcíaSara Hernando-Amado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.